To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CCDC137TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
201 supporting clones for gene CCDC137 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CN429631 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1 to 668 1 to 669   tiling clone,   669/669
(100 %)
1 diff
(99.9 %id)
BM548065 brain, hippocampus .a 329 to 1334 1 to 1012 R227Q P228A Q229P R230E S231E ...     1012/1061
(95 %)
23 diff
(97.9 %id)
BG421445 Kidney, renal cell adenocarcinoma .a 366 to 1063 1 to 731       731/1272
(57 %)
56 diff
(95.6 %id)
BE336863 Kidney, renal cell adenocarcinoma .a 368 to 882 1 to 516       516/516
(100 %)
4 diff
(99.3 %id)
NM_199287.2   .a 368 to 2476 1 to 2109   RefSeq,   2109/2109
(100 %)
1 diff
(100.0 %id)
BQ067809 brain .a 373 to 1269 19 to 922       904/1094
(82 %)
38 diff
(96.6 %id)
BF205421 muscle, rhabdomyosarcoma .a 383 to 1131 1 to 747       747/767
(97 %)
17 diff
(97.8 %id)
BG825039 muscle, rhabdomyosarcoma .a 383 to 1119 1 to 744       744/944
(78 %)
17 diff
(98.2 %id)
BC009369 Muscle, rhabdomyosarcoma .a 384 to 1953 1 to 1570   available from MGC, AAA   1570/1570
(100 %)
2 diff
(99.9 %id)
BE250906 eye, retinoblastoma .a 386 to 902 1 to 532       532/537
(99 %)
22 diff
(96.0 %id)
BQ226866 melanotic melanoma, skin .a 386 to 1020 1 to 643       643/983
(65 %)
13 diff
(98.7 %id)
BI521150 pooled pancreas and spleen .a 387 to 1280 1 to 905       903/907
(99 %)
51 diff
(94.4 %id)
CN429629 embryonic stem cells, cell lines H1, H7, andH9 .a 388 to 1104 1 to 717       717/717
(100 %)
2 diff
(99.8 %id)
BU506931 leiomyosarcoma, uterus .a 390 to 1323 1 to 942       942/945
(99 %)
34 diff
(96.5 %id)
CN429630 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 392 to 883 1 to 492   AAA   492/492
(100 %)
1 diff
(99.8 %id)
CR596466 HeLa cells Cot 25-normalized .a 393 to 2410 1 to 2018       2018/2018
(100 %)
0 diff
(100 %id)
BX337163 Placenta Cot 25-normalized .a 393 to 1485 1 to 1078   fully sequenced,   1078/1078
(100 %)
23 diff
(97.9 %id)
AL555382 placenta .a 393 to 1266 1 to 874       874/874
(100 %)
6 diff
(99.4 %id)
AW411383 muscle, rhabdomyosarcoma .a 393 to 987 21 to 615     Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 595/615
(96 %)
7 diff
(98.9 %id)
BG255244 adenocarcinoma, cell line, Prostate .a 393 to 1121 12 to 733       725/984
(73 %)
24 diff
(97.6 %id)
CN429626 embryonic stem cells, DMSO-treated H9 cellline .a 395 to 1000 1 to 606       606/606
(100 %)
2 diff
(99.7 %id)
TI_1948224579   .a 398 to 1063 123 to 790       668/1422
(46 %)
13 diff
(99.1 %id)
TI_1948224580   .a 398 to 1058 125 to 788       664/1401
(47 %)
17 diff
(98.8 %id)
TI_1948224881   .a 398 to 1156 117 to 877       761/1438
(52 %)
15 diff
(99.0 %id)
TI_1948224882   .a 398 to 980 118 to 701       584/1327
(44 %)
19 diff
(98.6 %id)
TI_1948225217   .a 398 to 1197 116 to 913       798/1409
(56 %)
23 diff
(98.4 %id)
TI_1948225544   .a 398 to 856 119 to 577       459/796
(57 %)
12 diff
(98.5 %id)
BX421890 T cells (Jurkat cell line) .a 399 to 1483 1 to 1069       1069/1069
(100 %)
28 diff
(97.4 %id)
TI_1948224884   .a 399 to 1272 1014 to 125       890/1347
(66 %)
31 diff
(97.7 %id)
BX375829 Neuroblastoma Cot 25-normalized .a 404 to 1341 1 to 925       925/950
(97 %)
19 diff
(98.0 %id)
EL735973 mixed .a 404 to 1021 1 to 618       618/618
(100 %)
4 diff
(99.4 %id)
CN429634 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 407 to 791 1 to 385       385/385
(100 %)
2 diff
(99.5 %id)
TI_1948224582   .a 407 to 1272 1002 to 132       871/1277
(68 %)
17 diff
(98.7 %id)
BE907810 epithelioid carcinoma, Pancreas .a 409 to 1161 1 to 759       692/856
(80 %)
24 diff
(97.2 %id)
BE745771 adenocarcinoma cell line, ovary .a 412 to 1158 1 to 748       748/1016
(73 %)
7 diff
(99.4 %id)
CR606833 Neuroblastoma Cot 25-normalized .a 418 to 2438 1 to 2021   tiling clone,   2021/2021
(100 %)
0 diff
(100 %id)
BX364477 Neuroblastoma Cot 25-normalized .a 418 to 1472 1 to 1051   fully sequenced,   1051/1051
(100 %)
18 diff
(98.3 %id)
BG437132 large cell carcinoma, lung .a 420 to 1342 1 to 938       936/945
(99 %)
37 diff
(96.1 %id)
TI_1948225220   .a 421 to 1272 976 to 124       853/1341
(63 %)
16 diff
(98.9 %id)
AI823401 Kidney .a 436 to 881 446 to 1       446/446
(100 %)
3 diff
(99.4 %id)
AW732610 Kidney, renal cell adenocarcinoma .a 451 to 940 1 to 490       490/490
(100 %)
2 diff
(99.6 %id)
CR983365 T-Lymphocytes .a 454 to 961 1 to 506       511/516
(99 %)
12 diff
(97.7 %id)
BF845797 lung_normal .a 496 to 847 365 to 18     Submitted on the opposite strand 348/380
(91 %)
0 diff
(100 %id)
AI695297 Kidney .a 505 to 881 377 to 1       377/377
(100 %)
4 diff
(99.0 %id)
BI823890 pooled brain, lung, testis .a 507 to 1287 1 to 782       782/782
(100 %)
9 diff
(98.9 %id)
TI_57201143   .a 507 to 1287 45 to 826       782/826
(94 %)
18 diff
(97.9 %id)
BU501511 brain, neuroblastoma, cell line .a 529 to 1338 1 to 826       826/964
(85 %)
34 diff
(96.5 %id)
TI_1948224883   .a 551 to 1272 848 to 123       726/1347
(53 %)
18 diff
(98.7 %id)
BG576074 breast, mammary adenocarcinoma, cell line .a 585 to 1356 13 to 785       773/785
(98 %)
15 diff
(98.1 %id)
BM790387 Ascites, stomach .a 588 to 1181 1 to 593       593/593
(100 %)
2 diff
(99.7 %id)
BM562958 astrocytoma grade IV, cell line, brain .a 590 to 1414 1 to 833       833/1067
(78 %)
17 diff
(98.5 %id)
AA903865 pooled germ cell tumors .a 619 to 891 273 to 1       273/273
(100 %)
1 diff
(99.7 %id)
BQ052512 blood, natural killer cells, cell line .a 641 to 1585 13 to 972       960/1112
(86 %)
37 diff
(96.7 %id)
TI_151773796   .a 663 to 1249 92 to 688     Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 597/1032
(57 %)
47 diff
(95.5 %id)
AI335539 pooled germ cell tumors .a 666 to 879 215 to 2       214/285
(75 %)
0 diff
(100 %id)
AI917713 pooled germ cell tumors .a 666 to 885 220 to 1       220/290
(75 %)
3 diff
(99.0 %id)
BE464127 pooled germ cell tumors .a 666 to 881 216 to 1       216/286
(75 %)
3 diff
(99.0 %id)
BI860818 breast, mammary adenocarcinoma, cell line .a 668 to 1434 1 to 769       769/779
(98 %)
6 diff
(99.3 %id)
TI_57192423   .a 668 to 1434 87 to 855       769/779
(98 %)
6 diff
(99.3 %id)
TI_1948224581   .a 672 to 1272 728 to 125       604/1364
(44 %)
7 diff
(99.5 %id)
BE252404 eye, retinoblastoma .a 679 to 1408 1 to 722       722/733
(98 %)
27 diff
(96.4 %id)
CN429632 embryonic stem cells, DMSO-treated H9 cellline .a 697 to 1150 1 to 452       452/452
(100 %)
3 diff
(99.4 %id)
BQ052393 blood, natural killer cells, cell line .a 701 to 1646 1 to 959       959/1076
(89 %)
43 diff
(96.1 %id)
BY994745   .a 737 to 1399 10 to 672       663/672
(98 %)
6 diff
(99.2 %id)
BE542134 cervix .a 739 to 1430 1 to 700       700/951
(73 %)
38 diff
(96.1 %id)
BQ684435 melanotic melanoma, cell line, skin .a 764 to 1301 1 to 539       539/1018
(52 %)
24 diff
(97.7 %id)
BQ681553 melanotic melanoma, cell line, skin .a 764 to 1708 1 to 946       946/946
(100 %)
27 diff
(97.2 %id)
EC472331 Prostate .a 802 to 882 83 to 3       81/83
(97 %)
0 diff
(100 %id)
CT001647 T-Lymphocytes .a 809 to 1445 1 to 637       637/639
(99 %)
1 diff
(99.9 %id)
BE882534 leiomyosarcoma, uterus .a 836 to 1642 1 to 812       812/1001
(81 %)
32 diff
(96.9 %id)
BU191448 ductal carcinoma, cell line, Pancreas .a 841 to 1616 1 to 785       785/957
(82 %)
19 diff
(98.1 %id)
BX372129   .a 899 to 1679 779 to 1       779/870
(89 %)
9 diff
(99.0 %id)
AA595405 Prostate, prostate tumor .a 911 to 1348 1 to 440     Submitted on the opposite strand 440/440
(100 %)
9 diff
(98.0 %id)
BG337747 leiomyosarcoma cell line, uterus .a 972 to 1725 1 to 752       752/953
(78 %)
21 diff
(97.8 %id)
BG340365 leiomyosarcoma cell line, uterus .a 972 to 1806 1 to 831       831/846
(98 %)
27 diff
(96.9 %id)
BF237672 leiomyosarcoma cell line, uterus .a 973 to 1787 2 to 814   AAA   813/947
(85 %)
46 diff
(95.2 %id)
AW867369 stomach_normal .a 987 to 1103 123 to 9       115/126
(91 %)
3 diff
(97.7 %id)
CN429633 embryonic stem cells, cell lines H1, H7, andH9 .a 989 to 1634 1 to 646       646/646
(100 %)
2 diff
(99.7 %id)
CV802236 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1016 to 1784 1 to 754       754/827
(91 %)
15 diff
(98.2 %id)
BG480062 choriocarcinoma, placenta .a 1042 to 1825 1 to 787       787/788
(99 %)
25 diff
(96.9 %id)
TI_154004043   .a 1089 to 1605 630 to 110       521/1114
(46 %)
24 diff
(97.9 %id)
BM042272 melanotic melanoma, cell line, skin .a 1113 to 1810 1 to 696   fully sequenced,   696/696
(100 %)
10 diff
(98.6 %id)
BU185923 melanotic melanoma, cell line, skin .a 1114 to 1893 26 to 814       789/935
(84 %)
26 diff
(97.3 %id)
BQ677067 melanotic melanoma, cell line, skin .a 1114 to 1893 24 to 810       787/1007
(78 %)
24 diff
(97.7 %id)
BQ882161 melanotic melanoma, cell line, skin .a 1114 to 1702 24 to 613       590/999
(59 %)
16 diff
(98.4 %id)
BU179246 melanotic melanoma, cell line, skin .a 1115 to 1899 1 to 800       800/933
(85 %)
23 diff
(97.6 %id)
BQ883434 melanotic melanoma, cell line, skin .a 1115 to 2021 1 to 916       916/922
(99 %)
37 diff
(96.0 %id)
BQ883800 melanotic melanoma, cell line, skin .a 1115 to 1842 1 to 729       729/957
(76 %)
15 diff
(98.5 %id)
BQ888437 melanotic melanoma, cell line, skin .a 1115 to 1712 1 to 600       600/1310
(45 %)
10 diff
(99.3 %id)
BQ683539 melanotic melanoma, cell line, skin .a 1115 to 1823 1 to 714       714/979
(72 %)
23 diff
(97.7 %id)
BQ677098 melanotic melanoma, cell line, skin .a 1115 to 2019 1 to 928       928/967
(95 %)
40 diff
(95.9 %id)
AW748178 breast .a 1154 to 1654 48 to 545       498/694
(71 %)
22 diff
(96.9 %id)
DR156996 human embryonic stem cells differentiated toan early endodermal cell type .a 1161 to 1902 1 to 742       742/742
(100 %)
3 diff
(99.6 %id)
BM797697 Ascites, stomach .a 1166 to 1519 1 to 354       354/354
(100 %)
1 diff
(99.8 %id)
CA433530 mixed .a 1187 to 1605 442 to 24   AAA   419/426
(98 %)
7 diff
(98.4 %id)
BQ439340 embryonal carcinoma, cell line, testis .a 1200 to 1980 1 to 781       781/787
(99 %)
18 diff
(97.8 %id)
DR763478 embryonic stem .a 1227 to 1972 1 to 746       746/746
(100 %)
0 diff
(100 %id)
BE279209 choriocarcinoma, placenta .a 1300 to 1826 1 to 536       536/537
(99 %)
17 diff
(96.9 %id)
BM726070 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1312 to 1951 1 to 640   fully sequenced,   640/640
(100 %)
3 diff
(99.6 %id)
BX375828 Neuroblastoma Cot 25-normalized .a 1368 to 2429 1059 to 1       1059/1108
(95 %)
15 diff
(98.7 %id)
AI857529 anaplastic oligodendroglioma, brain .a 1377 to 1964 588 to 1       588/588
(100 %)
3 diff
(99.5 %id)
TI_151716018   .a 1393 to 1967 696 to 120   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 577/577
(100 %)
8 diff
(98.7 %id)
BU157394 melanotic melanoma, cell line, skin .a 1406 to 1750 388 to 738       351/923
(38 %)
19 diff
(98.0 %id)
BC052272 Ovary, teratocarcinoma .a 1440 to 2464 1 to 1025   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 1025/1025
(100 %)
0 diff
(100 %id)
BX364476 Neuroblastoma Cot 25-normalized .a 1442 to 2407 968 to 28   fully sequenced,   941/968
(97 %)
22 diff
(97.8 %id)
BU553175 ovary, teratocarcinoma, cell line .a 1443 to 2103 1 to 664       664/975
(68 %)
14 diff
(98.6 %id)
BU931188 ovary, teratocarcinoma, cell line .a 1443 to 2300 1 to 871   available from MGC,   871/880
(98 %)
30 diff
(96.6 %id)
BX337162 Placenta Cot 25-normalized .a 1455 to 2434 995 to 27   fully sequenced,   969/995
(97 %)
19 diff
(98.1 %id)
CN290721 embryonic stem cells, DMSO-treated H9 cellline .a 1466 to 1776 1 to 311       311/311
(100 %)
3 diff
(99.1 %id)
CA422682 cell lines, Chondrosarcoma .a 1474 to 1967 512 to 19   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 494/494
(100 %)
0 diff
(100 %id)
BM682506 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1532 to 1973 442 to 1   fully sequenced,   442/442
(100 %)
2 diff
(99.6 %id)
BE208069 Kidney, renal cell adenocarcinoma .a 1533 to 1958 427 to 2       426/427
(99 %)
0 diff
(100 %id)
BX436058 T cells (Jurkat cell line) .a 1632 to 2459 833 to 1       833/840
(99 %)
13 diff
(98.5 %id)
BM042886 melanotic melanoma, cell line, skin .a 1780 to 2399 644 to 20   fully sequenced,   625/644
(97 %)
12 diff
(98.2 %id)
AW411384 muscle, rhabdomyosarcoma .a 2092 to 2464 444 to 72   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 373/373
(100 %)
25 diff
(93.3 %id)
BC021568 Eye, retinoblastoma .b 1 to 1885 1886 to 1 exact tiling clone, Submitted on the opposite strand 1886/2530
(74 %)
7 diff
(99.8 %id)
BF981661 duodenal adenocarcinoma, cell line, small intestine .b 903 to 1629 28 to 743       716/907
(78 %)
27 diff
(97.1 %id)
AI744329 ovary, tumor, 5 pooled (see description) .b 937 to 1376 440 to 1       440/440
(100 %)
2 diff
(99.6 %id)
AL577902 placenta .b 945 to 1822 878 to 1       878/878
(100 %)
5 diff
(99.5 %id)
TI_227715150   .b 949 to 1876 1007 to 89   AAA   919/1007
(91 %)
22 diff
(97.9 %id)
TI_149312184   .b 961 to 1885 996 to 82   AAA   915/941
(97 %)
22 diff
(97.7 %id)
TI_154115810   .b 966 to 1876 994 to 89   AAA   906/984
(92 %)
23 diff
(97.7 %id)
TI_149310542   .b 979 to 1876 977 to 90   AAA   888/943
(94 %)
12 diff
(98.8 %id)
TI_149309544   .b 982 to 1885 987 to 87   AAA   901/963
(93 %)
18 diff
(98.2 %id)
BX416354 neuroblastoma .b 996 to 1852 22 to 878       857/878
(97 %)
18 diff
(98.0 %id)
TI_154129285   .b 997 to 1876 971 to 94   AAA   878/992
(88 %)
23 diff
(97.7 %id)
AA010907 heart .b 1021 to 1483 1 to 466       466/466
(100 %)
14 diff
(97.0 %id)
AW407036 lymph .b 1026 to 1331 1 to 306       306/306
(100 %)
6 diff
(98.1 %id)
TI_154144874   .b 1033 to 1587 80 to 634       555/555
(100 %)
34 diff
(93.9 %id)
EC528209 Prostate .b 1067 to 1154 1 to 90       90/90
(100 %)
2 diff
(97.8 %id)
BM701908 eye, optic nerve .b 1075 to 1450 1 to 376   fully sequenced,   376/376
(100 %)
0 diff
(100 %id)
BG231660 blood, lymphocyte .b 1098 to 1376 279 to 1       279/279
(100 %)
2 diff
(99.3 %id)
BU590274 mixed (pool of 40 RNAs) .b 1104 to 1389 1 to 283       283/297
(95 %)
6 diff
(98.0 %id)
BU963208 mixed (pool of 40 RNAs) .b 1104 to 1364 1 to 261   AAA   261/261
(100 %)
0 diff
(100 %id)
BM700494 eye, lens .b 1116 to 1724 1 to 609       609/609
(100 %)
1 diff
(99.9 %id)
BM798021 Ascites, stomach .b 1122 to 1516 1 to 395       395/395
(100 %)
0 diff
(100 %id)
AA598792   .b 1127 to 1376 250 to 1       250/250
(100 %)
0 diff
(100 %id)
C14886   .b 1139 to 1435 1 to 295       295/295
(100 %)
4 diff
(98.7 %id)
BU689527 lung .b 1145 to 1885 761 to 19   AAA   743/743
(100 %)
7 diff
(99.1 %id)
BU687929 lung .b 1151 to 1885 757 to 19   AAA   739/739
(100 %)
6 diff
(99.2 %id)
CB528678 Aveolar Macrophage, lung .b 1165 to 1876 733 to 19   AAA   715/722
(99 %)
3 diff
(99.6 %id)
CB529888 Aveolar Macrophage, lung .b 1179 to 1876 718 to 19   AAA   700/700
(100 %)
5 diff
(99.3 %id)
CA449462 Chondrosarcoma, Left Pelvis .b 1194 to 1876 704 to 19   AAA   686/686
(100 %)
3 diff
(99.6 %id)
BU740298 eye, lens .b 1195 to 1876 701 to 19   AAA   683/683
(100 %)
6 diff
(99.2 %id)
BQ575236 Chondrosarcoma Grade II, Left Pelvis .b 1202 to 1885 702 to 19   tiling clone, AAA   684/684
(100 %)
0 diff
(100 %id)
BU688829 lung .b 1206 to 1876 687 to 19   AAA   669/669
(100 %)
1 diff
(99.9 %id)
CD365642 Alveolar Macrophage, lung .b 1206 to 1876 691 to 19   AAA   673/673
(100 %)
2 diff
(99.8 %id)
CA432091 cell lines, Enchondroma .b 1208 to 1876 686 to 19   AAA   668/668
(100 %)
3 diff
(99.6 %id)
BQ006311 Chondrosarcoma, Left Pelvis .b 1213 to 1876 686 to 19   AAA   668/668
(100 %)
5 diff
(99.3 %id)
CA437950 lung, Metastatic Chondrosarcoma .b 1226 to 1876 670 to 19   AAA   652/657
(99 %)
1 diff
(99.9 %id)
TI_154132881   .b 1244 to 1876 766 to 129   AAA   638/710
(89 %)
16 diff
(97.8 %id)
BF829663 head_normal .b 1245 to 1515 10 to 282       273/282
(96 %)
6 diff
(97.9 %id)
TI_149283556   .b 1283 to 1876 41 to 633   AAA Submitted on the opposite strand 593/633
(93 %)
6 diff
(99.1 %id)
CB854343 lung, Primary Lung Epithelial Cells .b 1286 to 1876 1 to 590   AAA Submitted on the opposite strand 590/590
(100 %)
5 diff
(99.2 %id)
BE250852 eye, retinoblastoma .b 1293 to 1864 573 to 1     Submitted on the opposite strand 573/574
(99 %)
10 diff
(98.3 %id)
N48733 multiple sclerosis lesions .b 1302 to 1590 1 to 291   fully sequenced,   291/291
(100 %)
3 diff
(99.0 %id)
BG057712 blood, lymphocyte .b 1337 to 1883 549 to 2       548/549
(99 %)
0 diff
(100 %id)
BF115231 fibrotheoma, ovary .b 1339 to 1877 539 to 1       539/539
(100 %)
0 diff
(100 %id)
CA417880 Chondrosarcoma Cell line .b 1348 to 1876 549 to 19   AAA   531/531
(100 %)
5 diff
(99.1 %id)
BF195200 brain, glioblastoma (pooled) .b 1356 to 1885 530 to 1       530/530
(100 %)
0 diff
(100 %id)
AI814598 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b 1370 to 1880 512 to 2       511/512
(99 %)
0 diff
(100 %id)
CA311895 Human Lung Epithelial cells, lung .b 1375 to 1885 529 to 19   AAA   511/520
(98 %)
0 diff
(100 %id)
AW445033   .b 1377 to 1876 517 to 18   AAA   500/500
(100 %)
0 diff
(100 %id)
AW575436 lymph .b 1377 to 1876 517 to 18   AAA   500/500
(100 %)
6 diff
(98.8 %id)
BU738073 eye, lens .b 1382 to 1876 513 to 19   AAA   495/495
(100 %)
0 diff
(100 %id)
BG230563 blood, lymphocyte .b 1392 to 1878 487 to 1       487/487
(100 %)
0 diff
(100 %id)
BM798403 Ascites, stomach .b 1392 to 1592 1 to 201       201/201
(100 %)
0 diff
(100 %id)
BF828297 head_normal .b 1393 to 1583 190 to 1     Submitted on the opposite strand 190/217
(87 %)
10 diff
(95.4 %id)
AA639679 breast .b 1399 to 1876 477 to 1       477/477
(100 %)
1 diff
(99.8 %id)
W49499 senescent fibroblast .b 1403 to 1888 488 to 3       486/488
(99 %)
0 diff
(100 %id)
AI991334 colon, colonic mucosa from 3 patients with Crohn'sdisease .b 1410 to 1879 470 to 1       470/470
(100 %)
0 diff
(100 %id)
BM671063 eye, optic nerve .b 1420 to 1876 478 to 19   fully sequenced, AAA   460/460
(100 %)
3 diff
(99.4 %id)
AI093140 heart .b 1427 to 1876 460 to 11   AAA   450/450
(100 %)
0 diff
(100 %id)
AW664253 2 pooled high-grade transitional celltumors, genitourinary tract .b 1427 to 1883 471 to 15   AAA   457/457
(100 %)
2 diff
(99.6 %id)
AI201901 Prostate .b 1438 to 1880 443 to 1       443/443
(100 %)
0 diff
(100 %id)
AI870937 anaplastic oligodendroglioma, brain .b 1438 to 1876 439 to 1       439/439
(100 %)
0 diff
(100 %id)
AI376291   .b 1452 to 1888 440 to 4   tiling clone,   437/440
(99 %)
0 diff
(100 %id)
AI144136 brain, glioblastoma (pooled) .b 1453 to 1880 432 to 5       428/432
(99 %)
0 diff
(100 %id)
AI278136 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1461 to 1887 427 to 1       427/427
(100 %)
0 diff
(100 %id)
AA970973 Kidney, kidney tumor .b 1462 to 1880 424 to 6       419/424
(98 %)
0 diff
(100 %id)
R50194 breast .b 1492 to 1880 1 to 397   fully sequenced,   397/397
(100 %)
15 diff
(96.3 %id)
H25905 breast .b 1549 to 1880 1 to 336       336/337
(99 %)
6 diff
(98.3 %id)
AI933207 anaplastic oligodendroglioma, brain .b 1556 to 1876 321 to 1       321/321
(100 %)
1 diff
(99.7 %id)
N56867 multiple sclerosis lesions .b 1560 to 1877 319 to 1   fully sequenced,   319/319
(100 %)
0 diff
(100 %id)
AA569385 colon, colon tumor RER+ .b 1583 to 1888 309 to 4       306/309
(99 %)
0 diff
(100 %id)
BF828288 head_normal .b 1598 to 1837 253 to 16     Submitted on the opposite strand 238/253
(94 %)
0 diff
(100 %id)
BE140181 head_neck .b 1610 to 1777 1 to 168       168/168
(100 %)
6 diff
(96.5 %id)
AA011298 heart .b 1628 to 1876 253 to 1       253/260
(97 %)
8 diff
(97.0 %id)
BG056030 anaplastic oligodendroglioma, brain .b 1647 to 1888 242 to 1       242/242
(100 %)
0 diff
(100 %id)
BG056094 anaplastic oligodendroglioma, brain .b 1647 to 1888 242 to 1       242/242
(100 %)
0 diff
(100 %id)
BG056095 anaplastic oligodendroglioma, brain .b 1647 to 1887 241 to 1       241/241
(100 %)
0 diff
(100 %id)
BG055723 anaplastic oligodendroglioma, brain .b 1647 to 1888 242 to 1       242/242
(100 %)
0 diff
(100 %id)
R50139 breast .b 1696 to 1876 185 to 1   fully sequenced,   185/185
(100 %)
1 diff
(99.5 %id)
BX451388 neuroblastoma .b 1743 to 1880 1 to 136       136/138
(98 %)
4 diff
(97.2 %id)
BQ920725 carcinoma, cell line, Prostate .c 1 to 811 1 to 818 M239D L240A L241S S242E G244R ... tiling clone,   818/915
(89 %)
10 diff
(99.0 %id)
BG493683 lung, mucoepidermoid carcinoma .d 1 to 620 1 to 647 R5L G6W D7R G8W G9L ... tiling clone,   647/702
(92 %)
56 diff
(92.1 %id)
BM466413 eye, retinoblastoma .d 25 to 462 1 to 439   tiling clone,   439/1308
(33 %)
7 diff
(99.5 %id)
DB323257   .e 1 to 531 1 to 531   tiling clone, Submitted on the opposite strand 531/531
(100 %)
1 diff
(99.9 %id)
BG287265 bladder, transitional cell papilloma, cell line .e 431 to 911 1 to 481 I122T L137M H150N L151S T152L ... tiling clone,   780/1170
(66 %)
19 diff
(98.4 %id)
AA366499 Pancreas .f-u 1 to 318 1 to 322   tiling clone,   322/334
(96 %)
9 diff
(97.4 %id)
AV722332 hypothalamus .f-u 60 to 745 684 to 1   tiling clone, Submitted on the opposite strand 684/688
(99 %)
4 diff
(99.5 %id)
AI133038 Liver .f-u 184 to 392 1 to 209       209/209
(100 %)
2 diff
(99.1 %id)
AV724839 hypothalamus .f-u 304 to 745 458 to 22     Submitted on the opposite strand 437/460
(95 %)
0 diff
(100 %id)
BM041288 Kidney, Wilms' tumor, cell line .f-u 664 to 1064 267 to 673   tiling clone,   407/891
(45 %)
6 diff
(99.4 %id)
BF924612 nervous_tumor .g 1 to 267 1 to 270 G3C tiling clone,   267/270
(98 %)
4 diff
(98.6 %id)
BE937720 testis_normal .h-u 1 to 225 228 to 1 F16L R17A L18A R19P E20G ... tiling clone,   228/240
(95 %)
11 diff
(95.5 %id)
AA554311 colon Gene CCDC137, variant not shown         Suspected internal deletion, this clone was ignored    
AI351768 pooled germ cell tumors Gene CCDC137, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
AI265820 borderline ovarian carcinoma, ovary Gene CCDC137, variant not shown         Suspected internal deletion, this clone was ignored    
BQ027796 mixed Gene CCDC137, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BE743422 adenocarcinoma cell line, ovary Gene CCDC137, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
TI_149270972   Gene CCDC137, variant not shown       AAA This clone was ignored    
TI_158431353   Gene CCDC137, variant not shown       AAA This clone was ignored    
CF528574 placenta Gene CCDC137, variant not shown       AAA This clone was ignored    
BU674115 lung, Primary Lung Epithelial Cells Gene CCDC137, variant not shown       AAA This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g, .h-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI